Min Jie Zeng

Min Jie Zeng serves as a secondary procurement specialist within the FDA Office of Acquisitions and Grants Services, supporting the agency’s mission to safeguard public health through strategic acquisition of advanced technical services. While not the primary contracting officer, Zeng plays a critical role in facilitating the planning, evaluation, and execution of IT and systems design acquisitions aligned with the FDA’s regulatory science priorities. Their work centers on ensuring compliance with federal procurement regulations while enabling the adoption of digital infrastructure, analytical tools, and innovation in regulatory decision-making, particularly in areas such as digital twins and data-driven manufacturing oversight. Zeng collaborates closely with a diverse pool of contractors specializing in computer systems design and related technical services, often working in tandem with primary contracting officers to assess vendor capabilities, evaluate technical proposals, and ensure alignment with FDA’s scientific and operational needs. Their engagement pattern reflects a preference for agile, responsive vendors capable of delivering scalable, secure, and interoperable solutions, with consistent interaction across both large-capability firms and small business partners. Zeng demonstrates a balanced commitment to socioeconomic contracting, with an equal split between total small business set-asides and open competitions under FAR 19.5. This reflects a deliberate strategy to foster competition while ensuring meaningful participation from small businesses, particularly those certified under the Small Business Administration’s programs. There is no indication of preference for 8(a), HUBZone, or SDVOSB set-asides, suggesting a focus on broad small business inclusion rather than targeted socioeconomic categories. The primary procurement focus lies in NAICS 541512 (Computer Systems Design Services) and 541519 (Other Computer Related Services), underscoring expertise in procuring custom software development, data analytics platforms, modeling and simulation tools, and digital infrastructure supporting regulatory science. Zeng’s technical domain knowledge centers on modernizing FDA’s digital ecosystem to enhance product safety evaluation and accelerate innovation in medical product development.